Clinical Trial Update: Study of IMC-11F8 in Participants With Advanced Solid Tumors [Phase 1]

View source ↗

Summary

A Phase 1 study of IMC-11F8 in participants with advanced solid tumors has completed, and the results have been posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cancer

Drugs mentioned

• IMC-11F8

Snippet

Sponsor: Eli Lilly and Company | Conditions: Neoplasms | Phase 1 | Status: COMPLETED | Results posted: 2017-02-03